SLC2A1 expression and glucose metabolism were increased in tumor-associated neutrophils from mouse models of lung adenocarcinoma compared with normal neutrophils, and tumor growth was slowed and radiotherapy effects were enhanced when SLC2A1 expression was absent in tumor-associated neutrophils (Ancey et al., 2021). This evidence concerns the gene SLC2A1 and lung adenocarcinoma.